Close
Nordic 9Nordic 9

Erasmus MC (investor - Corporate Investor)

Netherlands erasmusmc.nl
See something wrong or missing? Let us know
Offices:Rotterdam
Average round investment:5.95M USD
Average number per year:1.0
Distribution: 2025 (1)2024 (1)2023 (1)
Portfolio companies: Netherlands Pan Cancer
Mostly invests in: Netherlands Netherlands (3) Biotech (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Erasmus MC mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Erasmus MC

Name Criteria
United States Life Science Angels
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Thomas Würdinger
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Netherlands Enterprise Agency
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Netherlands Van Herk Ventures
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
France Yaday
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Belgium Flanders Future Techfund (FFTF)
81%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
France Truffle Capital
81%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Netherlands Borski Fund
81%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 3.2
  • Active last 12 months: Yes
France Didier Valet
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Active last 12 months: Yes
Sweden Linc Invest
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top